The clinical spectrum of preeclampsia: Comparative study of its different grades of severity;Espectro clínico de la preeclampsia: Estudio comparativo de sus diversos grados de severidad

Revista Chilena de Obstetricia y Ginecologia

Volumn 72, Issue 3, 2007, Pages 169-175

  Parra C , Mauro ^a   San Martín O , Alfredo ^b   Valdés R , Enrique ^a   Hasbún H , Jorge ^a   Quiroz V , Lorena ^a   Schepeler S , Manuel ^a   Pérez B , Sebastián ^a   Rau M , Carlos ^a   Miranda O , Juan Pablo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

HELLP syndrome; Maternal and neonatal outcome; Preeclampsia

Indexed keywords

EID: 34548236903     PISSN: 0048766X     EISSN: 07177526     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Egerman RS, Sibai BM. HELLP Syndrome. Clin Obstet Gynecol 1999;42(2):381-9.
2. Villar K, Say L, Gülmezoglu AM, Merialdi M, Lindheimer MD, Betran AP, Piaggio G. Eclampsia and pre-eclampsia: a health problem for 2000 years. In: Critchley H, MacLean AB, Poston L, Walker JJ (eds). PRE-ECLAMPSIA. London: RCOG Press: 2003; 189-207.
3. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181-92.
4. Valdés G, Oyarzún E. Síndromes hipertensivos del embarazo. En: Pérez A, Donoso E (eds). OBSTETRICIA. Santiago, Chile: Publicaciones Técnicas Mediterráneo 1999;52-60
5. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
6. Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta 2002;23(5):359-72.
7. Noris M, Perico N, Remuzzi G. Mechanisms of disease: Pre-eclampsia. Nat Clin Pract Nephrol 2005;1(2):98-114.
8. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365(9461):785-99.
9. Geller SE, Rosenberg D, Cox SM, Brown ML, Simonson L, Driscoll CA, Kilpatrick SJ. The continuum of maternal morbility and mortality: factor associated with severity. Am J Obstet Gynecol 2004;191(3):939-44.
10. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142(2):159-67.
11. Fish R. The HELLP syndrome: a case report and review of the literature. J Emerg Med 1993;11(2):169-74.
12. Abroug F, Boujdaria R, Nouria S, Abroug S, Sousisi M, Najjar MF, et al. Hellp syndrome: incidence and maternal-fetal outcome-a prospective study. Intensive Care Med 1992;18(5):274-7.
13. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155(3):501-9.
14. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzimes, and low platelet count. Obstet Gynecol 2004;103(5 Pt 1):981-91.
15. Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM. Neonatal outcome in severe preeclampsia at 24 to 36 weeks gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 1999;180(1 Pt1):221-5.
16. Cunningham F, Fernandez C, Hernandez C. Blindness associated with preeclampsia and eclampsia. Am J Obstet Gynecol 1995;172(4):1291-98.
17. Hadad B, Barton JR, Livingston JC, Chahine R, Sibai BM. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: Onset at ≤28.0 weeks' gestation. Am J Obstet Gynecol 2000;183 (6):1475-9
18. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002;100(2):369-77.
19. Mackay AP, Berg CJ, Atrash HK. Pregnancy related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001;97:533-8.
20. Le Thi Thuong D, Tieulié N, Costedoat N, Andreu MR, Wechsler B, Vauthier-Brouzes D, et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005;64;273-278.
21. Donoso E. Reducción de la mortalidad materna en Chile de 1990 a 2000. Rev Panam Salud Pública 2004;15(5):326-30.
22. Walker MC, Murphy KE, Pan S, Yang Q, Wen SW. Adverse maternal outcomes in multifetal pregnancies. BJOG 2004;111(11):1294-6.
23. Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000;182(4):938-42.
24. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12(6):642-9.
25. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribuye to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.